Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/23/1995 | CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors |
11/23/1995 | CA2189975A1 Peptide-mediated gene transfer |
11/23/1995 | CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel |
11/23/1995 | CA2189421A1 Collagen from cell cultures |
11/23/1995 | CA2188562A1 Method of introducing pathogen resistance in plants |
11/23/1995 | CA2188421A1 Alphavirus expression vector |
11/23/1995 | CA2188157A1 Nucleic acid sequences controlling lung cell-specific gene expression |
11/23/1995 | CA2186615A1 Novel enzymatic rna molecules |
11/23/1995 | CA2158926A1 Compositions and methods for targeting gene delivery vehicles |
11/22/1995 | EP0683238A2 A process for the cloning of DNA |
11/22/1995 | EP0683230A1 Vitreoscilla haemoglobin promoter/regulator controlled by the level of oxygen |
11/22/1995 | EP0683229A2 Process for the preparation of recombinant aprotinin and recombinant aprotinin variants with natural N-terminal sequence |
11/22/1995 | EP0683228A2 Novel expression system |
11/22/1995 | EP0683227A1 Human retinoic acid receptor and genes encoding for it |
11/22/1995 | EP0683226A1 Transgenic animals as a model for metabolic bone diseases |
11/22/1995 | EP0682950A1 Mucosal administration of pneumococcal antigens |
11/22/1995 | EP0682716A1 Rna assays using rna binary probes and ribozyme ligase |
11/22/1995 | EP0682715A1 Diagnostic assays and kits for rna using rna binary probes and an rna-directed rna ligase |
11/22/1995 | EP0682714A1 Novel neutrophil inhibitors |
11/22/1995 | EP0682712A1 Human interferon expression vectors for treating aids |
11/22/1995 | EP0682711A1 Plants resistant to infection by plrv |
11/22/1995 | EP0682710A1 Immobilized proteins with specific binding capacities and their use in processes and products |
11/22/1995 | EP0682709A1 Fusion proteins including a cleavage site recognized by a plant virus protease |
11/22/1995 | EP0682708A1 Antiviral composition of viral protein trans-dominant variants |
11/22/1995 | EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
11/22/1995 | EP0682706A1 Novel compounds |
11/22/1995 | EP0682705A1 Tnf-alpha muteins and a process for preparing them |
11/22/1995 | EP0682704A1 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
11/22/1995 | EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
11/22/1995 | EP0682702A1 Expression of protective antigens |
11/22/1995 | EP0682701A1 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS |
11/22/1995 | EP0682700A1 Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis |
11/22/1995 | EP0682699A1 FUNCTIONAL DOMAINS IN $i(FLAVOBACTERIUM OKEANOKOITES) (FOKI) RESTRICTION ENDONUCLEASE |
11/22/1995 | EP0682671A1 Methods and apparatus for dna sequencing |
11/22/1995 | EP0682529A1 Antibody for the treatment of insulin dependent diabetes |
11/22/1995 | EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
11/22/1995 | EP0571475B1 Sg(beta)-1,4-GALACTANASE AND A DNA SEQUENCE |
11/22/1995 | EP0485608B1 Method for obtaining polypeptides in a cell-free translation system |
11/22/1995 | EP0427788B1 Methods for isolating herpes virus thymidine kinase-encoding dna |
11/22/1995 | CN1112356A Novel attenuated pseudomonas aeruginosa strains |
11/22/1995 | CN1112142A Microcapsule-type curing agent, method for producing the same, thermosetting resin composition, prepreg and fiber reinforced composite material |
11/22/1995 | CN1112127A A novel polypeptide of protein p140 and DNAS encoding it |
11/22/1995 | CN1112126A Polyamid-oligonucleotide derivative, preparation and application of same |
11/21/1995 | US5468851 Construction of geometrical objects from polynucleotides |
11/21/1995 | US5468637 S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones |
11/21/1995 | US5468636 Aphidicides |
11/21/1995 | US5468634 Axl oncogene |
11/21/1995 | US5468631 Genetic engineering |
11/21/1995 | US5468630 cDNA clone for human inducible nitric oxide synthase and process for preparing same |
11/21/1995 | US5468629 Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein |
11/21/1995 | US5468624 Polynucleotide with sequyence code and cells |
11/21/1995 | US5468615 Adding a compound to eukaryotic cell transformed with vector capable of expressing human dopamine receptor, assaying affinity of compound for receptor |
11/21/1995 | US5468614 System to detect protein-protein interactions |
11/21/1995 | US5468613 Process for detecting specific nucleotide variations and genetic polymorphisms present in nucleic acids |
11/21/1995 | US5468609 Production of interferon |
11/21/1995 | US5468608 Production of interferon |
11/21/1995 | US5468607 Production of interferon |
11/21/1995 | US5468485 Avirulent microbes and uses therefor |
11/21/1995 | US5468483 Bacillus thuringiensis anti-giardia treatment |
11/21/1995 | US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD |
11/21/1995 | CA2149703A1 Mucosal administration of pneumococcal antigens |
11/21/1995 | CA2149345A1 Epitopic regions of pneumococcal surface protein a |
11/21/1995 | CA1337597C Phosphinotricin-resistance gene, and its use |
11/21/1995 | CA1337596C Varicella-zoster virus as a live recombinant vaccine |
11/19/1995 | CA2149375A1 Process for preparing recombinant aprotinin and recombinant aprotinin variants having the natural n-terminal sequence |
11/18/1995 | CA2148724A1 Cloning and expression of a gene encoding bryodin 1 from bryonia dioica |
11/16/1995 | WO1995030775A1 High-affinity ligands of insulin receptor antibodies, tachykinin substance p, hiv integrase and hiv-1 reverse transcriptase |
11/16/1995 | WO1995030773A1 Method of nucleic acid transfer |
11/16/1995 | WO1995030772A1 Method of detecting human cytochrome p4502d6 gene polymorphism |
11/16/1995 | WO1995030768A1 Method and apparatus for counting cells and microorganisms, particularly in food and biological fluids |
11/16/1995 | WO1995030763A2 Retroviral vectors having a reduced recombination rate |
11/16/1995 | WO1995030762A1 Sv-40 derived dna constructs comprising exogenous dna sequences |
11/16/1995 | WO1995030761A2 Methods of in vivo gene delivery |
11/16/1995 | WO1995030759A1 Biologically active polypeptides inserted into an albumin |
11/16/1995 | WO1995030758A1 Recombinant hk2 polypeptide |
11/16/1995 | WO1995030757A2 Metalloproteases from fusarium and aspergillus having thermolysin-like activity |
11/16/1995 | WO1995030756A1 Thermostable alkaline phosphatase of thermus thermophilus |
11/16/1995 | WO1995030755A1 Recombinant human immunodeficiency virus vector and process for producing the same |
11/16/1995 | WO1995030754A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
11/16/1995 | WO1995030753A1 CHIMERIC DELTA-ENDOTOXIN EXPRESSION IN $i(PSEUDOMONAS FLUORESCENS) |
11/16/1995 | WO1995030752A1 IMPROVED BACILLUS THURINGIENSIS δ-ENDOTOXIN |
11/16/1995 | WO1995030751A1 Lanthionine-containing antimicrobial compound |
11/16/1995 | WO1995030750A2 Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
11/16/1995 | WO1995030748A2 Plant u14 nucleic acid sequences and derivatives thereof |
11/16/1995 | WO1995030747A1 Plant u14 nucleic acid sequences and derivatives thereof |
11/16/1995 | WO1995030746A1 Antisense inhibition of hepatitis c virus |
11/16/1995 | WO1995030744A2 Lipases with improved surfactant resistance |
11/16/1995 | WO1995030743A1 Protease variants |
11/16/1995 | WO1995030741A1 Receptor-deficient animals and cell lines derived therefrom, and uses thereof |
11/16/1995 | WO1995030739A1 Light-regulated promoters for production of heterologous proteins in filamentous fungi |
11/16/1995 | WO1995030695A1 Interleukin-15 receptors |
11/16/1995 | WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins |
11/16/1995 | WO1995030686A1 Production of biologically active recombinant neurotrophic protein |
11/16/1995 | WO1995030685A1 An enzymatic process for producing a desired protein from an amino terminal extended protein |
11/16/1995 | WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons |
11/16/1995 | WO1995030428A1 Human dnase |
11/16/1995 | WO1995030339A1 Cloning, expression, and uses of human lactoferrin |
11/16/1995 | WO1995030330A1 Method for in vivo delivery of therapeutic agents via liposomes |
11/16/1995 | WO1995027080A3 Dna sequencing by stepwise ligation and cleavage |
11/16/1995 | WO1995025801A3 Viral replicon |